SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-004320
Filing Date
2024-01-30
Accepted
2024-01-30 16:23:47
Documents
16
Period of Report
2024-01-30
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43593
2 ex3-1.htm EX-3.1 1122
3 ex3-1_001.jpg GRAPHIC 384467
  Complete submission text file 0001493152-24-004320.txt   745396

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE sigy-20240130.xsd EX-101.SCH 3042
5 XBRL LABEL FILE sigy-20240130_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE sigy-20240130_pre.xml EX-101.PRE 22377
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3425
Mailing Address 9190 W OLYMPIC BLVD # 263 BEVERLY HILLS CA 90212
Business Address 9190 W OLYMPIC BLVD # 263 BEVERLY HILLS CA 90212 619-368-2000
Sigyn Therapeutics, Inc. (Filer) CIK: 0001642159 (see all company filings)

IRS No.: 472573116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55575 | Film No.: 24578497
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)